Newsfeeds - Spark Newswire

3 minute read

Arvinas Announces ARV-471 Achieved Clinical Benefit Rate Of 38% In Evaluable Patients And Continues To Show A Favorable Tolerability Profile In Its Phase 2 Expansion Trial

Today, 4:48 AM

ARV-471 continues to show activity in heavily pre-treated patients with locally advanced or metastatic ER+/HER2- breast cancer Median progression free survival of 3.7 months in all patients and 5.7 months in

ARVN

1 minute read

SVB Leerink Maintains Outperform on Arvinas, Lowers Price Target to $74

By Benzinga Newsdesk

Today, 4:48 AM

SVB Leerink analyst Andrew Berens maintains Arvinas (NASDAQ:ARVN) with a Outperform and lowers the price target from $89 to $74.

ARVN

5 minute read

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:48 AM

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

ACRV

3 minute read

Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 4:48 AM

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.

ARVN

5 minute read

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:48 AM

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.

$APE

2 minute read

Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

Today, 4:48 AM

U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

AGYS

1 minute read

Analyst Ratings

Where Arvinas Stands With Analysts

By Benzinga Insights

Today, 4:48 AM

Within the last quarter, Arvinas (NASDAQ:ARVN) has observed the following analyst ratings:

ARVN

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 9, 2022

By Benzinga Insights

Today, 4:48 AM

Upgrades

ADCT

2 minute read

Sanofi, Children’s Place And Some Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

Today, 4:48 AM

Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.

ARVN

4 minute read

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 4:48 AM

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.